Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,057 public trials 2,038 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Efficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHL

NCT00311129

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Nagoya, Aichi-ken, Japan

Nagoya, Aichi-ken, Japan

Kashiwa-shi, Chiba, Japan

Isehara-shi, Kanagawa, Japan

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease

NCT00003421

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations: St. James's Hospital Leeds, England, United Kingdom

Weston Park Hospital Sheffield, England, United Kingdom

View Trial Details

Completed

A Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or Thrombocytopenia

NCT00220311

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

Vitalis Study - Observational Study on the Quality of Life in Patients Under Treatment for B-Chronic Lymphocytic Leukemia (B-CLL)

NCT00344825

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations: Many Locations, Italy

View Trial Details

Completed

Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma

NCT01129180

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +35 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

A Study of JNJ-26866138 (Bortezomib) in Untreated Multiple Myeloma Patients Who Are Not Candidates for Hematopoietic Stem Cell Transplant (HSCT)

NCT00985959

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Fukuoka, Japan

Hiroshima, Japan

Hitachi, Japan

Isehara, Japan

View all 28 locations

View Trial Details

Completed

Bioequivalence of An Oral Mercaptopurine Suspension 100 Mg / 5 Ml Versus Tablet in Healthy Male Subjects Under Fasting Conditions

NCT01697020

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Parexel International, Bloemfontein Early Phase Clinical Unit Bloemfontein, South Africa

View Trial Details

Completed

Bortezomib and Dexamethasone Followed by ASCT Compared With ASCT Alone in Treating Patients With AL Amyloidosis

NCT01998503

Conditions: Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +9 more
Locations: Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine Nanjing, Jiangsu, China

View Trial Details

Completed

Velcade in MALT Lymphoma Patients

NCT00373906

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Not specified

View Trial Details

Completed

Diffuse Fibrotic Lung Disease

NCT00000596

Conditions: Fibrosis, Hemic and Lymphatic Diseases, Hypersensitivity, +11 more
Locations: Not specified

View Trial Details